Trial
NCT05935774
OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Genentech, Inc.; Oncotelic Therapeutics, Inc.
Condition
Metastatic Lung Non-Small Cell Carcinoma
Intervention
Atezolizumab
Why stopped
Withdrawn prior to opening to accrual.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-08-25